Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pancreatitis

  Free Subscription


Articles published in J Gastroenterol

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    July 2021
  1. CANNON A, Thompson CM, Bhatia R, Armstrong KA, et al
    Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2021 Jul 19. pii: 10.1007/s00535-021-01800.
    PubMed     Abstract available


  2. ASTIAZARAN-SYMONDS E, Goldstein AM
    A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer.
    J Gastroenterol. 2021 Jul 13. pii: 10.1007/s00535-021-01806.
    PubMed     Abstract available


    June 2021
  3. KURIYAMA K, Kodama Y, Shiokawa M, Nishikawa Y, et al
    Essential role of Notch/Hes1 signaling in postnatal pancreatic exocrine development.
    J Gastroenterol. 2021 Jun 14. pii: 10.1007/s00535-021-01779.
    PubMed     Abstract available


    March 2021
  4. WANG WQ, Zhang WH, Gao HL, Huang D, et al
    A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors.
    J Gastroenterol. 2021 Mar 19. pii: 10.1007/s00535-021-01777.
    PubMed     Abstract available


    February 2021
  5. LAI SW
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 5. pii: 10.1007/s00535-021-01764.
    PubMed    


  6. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 2. pii: 10.1007/s00535-021-01761.
    PubMed    


    October 2020
  7. SAKAI A, Masuda A, Eguchi T, Anami T, et al
    Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation.
    J Gastroenterol. 2020 Oct 28. pii: 10.1007/s00535-020-01739.
    PubMed     Abstract available


  8. TEZUKA K, Okamura Y, Sugiura T, Ito T, et al
    The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy.
    J Gastroenterol. 2020 Oct 22. pii: 10.1007/s00535-020-01730.
    PubMed     Abstract available


    September 2020
  9. OKADA T, Mizukami Y, Ono Y, Sato H, et al
    Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance.
    J Gastroenterol. 2020 Sep 16. pii: 10.1007/s00535-020-01724.
    PubMed     Abstract available


    July 2020
  10. DUNBAR E, Greer PJ, Melhem N, Alkaade S, et al
    Constant-severe pain in chronic pancreatitis is associated with genetic loci for major depression in the NAPS2 cohort.
    J Gastroenterol. 2020 Jul 17. pii: 10.1007/s00535-020-01703.
    PubMed     Abstract available


  11. MASAMUNE A, Kikuta K, Kume K, Hamada S, et al
    Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019.
    J Gastroenterol. 2020 Jul 16. pii: 10.1007/s00535-020-01704.
    PubMed     Abstract available


    June 2020
  12. BHARMAL SH, Cho J, Alarcon Ramos GC, Ko J, et al
    Trajectories of glycaemia following acute pancreatitis: a prospective longitudinal cohort study with 24 months follow-up.
    J Gastroenterol. 2020 Jun 3. pii: 10.1007/s00535-020-01682.
    PubMed     Abstract available


    May 2020
  13. ITO T, Tanaka T, Nakamaru K, Tomiyama T, et al
    Interleukin-35 promotes the differentiation of regulatory T cells and suppresses Th2 response in IgG4-related type 1 autoimmune pancreatitis.
    J Gastroenterol. 2020 May 6. pii: 10.1007/s00535-020-01689.
    PubMed     Abstract available


    February 2020
  14. HAMADA T, Ogino S, Wolpin BM
    Response to the letter by Lai et al. regarding our manuscript "Statin use and pancreatic cancer risk in two prospective cohort studies".
    J Gastroenterol. 2020 Feb 14. pii: 10.1007/s00535-020-01676.
    PubMed    


  15. LAI SW, Kuo YH, Liao KF
    Statins and pancreatic cancer risk.
    J Gastroenterol. 2020 Feb 8. pii: 10.1007/s00535-020-01675.
    PubMed    


    January 2020
  16. OKUSAKA T, Furuse J
    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines.
    J Gastroenterol. 2020 Jan 29. pii: 10.1007/s00535-020-01666.
    PubMed     Abstract available


  17. MINAGA K, Watanabe T, Arai Y, Shiokawa M, et al
    Activation of interferon regulatory factor 7 in plasmacytoid dendritic cells promotes experimental autoimmune pancreatitis.
    J Gastroenterol. 2020 Jan 20. pii: 10.1007/s00535-020-01662.
    PubMed     Abstract available


    December 2019
  18. MASAMUNE A, Kikuta K, Hamada S, Tsuji I, et al
    Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.
    J Gastroenterol. 2019 Dec 23. pii: 10.1007/s00535-019-01658.
    PubMed     Abstract available


  19. KURITA Y, Hara K, Kuwahara T, Mizuno N, et al
    Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
    J Gastroenterol. 2019 Dec 19. pii: 10.1007/s00535-019-01655.
    PubMed     Abstract available


  20. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.
    J Gastroenterol. 2019 Dec 6. pii: 10.1007/s00535-019-01652.
    PubMed     Abstract available


    November 2019
  21. HIROTA M, Shimosegawa T, Kitamura K, Takeda K, et al
    Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial.
    J Gastroenterol. 2019 Nov 22. pii: 10.1007/s00535-019-01644.
    PubMed     Abstract available


    September 2019
  22. LIU Y, Wang D, Li ZS, Hu LH, et al
    Study of early chronic pancreatitis needs to be improved.
    J Gastroenterol. 2019 Sep 26. pii: 10.1007/s00535-019-01632.
    PubMed    


  23. KIKUTA K, Masamune A
    Reply to "Study of Early Chronic Pancreatitis Needs to be Improved".
    J Gastroenterol. 2019 Sep 23. pii: 10.1007/s00535-019-01631.
    PubMed    


    August 2019
  24. HAKUTA R, Hamada T, Nakai Y, Oyama H, et al
    Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes.
    J Gastroenterol. 2019 Aug 31. pii: 10.1007/s00535-019-01612.
    PubMed     Abstract available


  25. NOGUCHI K, Nakai Y, Mizuno S, Isayama H, et al
    Insulin secretion improvement during steroid therapy for autoimmune pancreatitis according to the onset of diabetes mellitus.
    J Gastroenterol. 2019 Aug 30. pii: 10.1007/s00535-019-01615.
    PubMed     Abstract available


  26. HEDEGGER K, Stumpf F, Blum H, Graf A, et al
    The protective effect of betacellulin against acute pancreatitis is ERBB4 dependent.
    J Gastroenterol. 2019 Aug 27. pii: 10.1007/s00535-019-01613.
    PubMed     Abstract available


    July 2019
  27. MASAMUNE A, Nabeshima T, Kikuta K, Hamada S, et al
    Prospective study of early chronic pancreatitis diagnosed based on the Japanese diagnostic criteria.
    J Gastroenterol. 2019 Jul 3. pii: 10.1007/s00535-019-01602.
    PubMed     Abstract available


    June 2019
  28. KOHLI DR, Smith KR, Wong J, Yu Z, et al
    Familial pancreatic cancer risk: a population-based study in Utah.
    J Gastroenterol. 2019 Jun 25. pii: 10.1007/s00535-019-01597.
    PubMed     Abstract available


    May 2019
  29. HAYAKAWA H, Fukasawa M, Sato T, Takano S, et al
    Carcinoembryonic antigen level in the pancreatic juice is effective in malignancy diagnosis and prediction of future malignant transformation of intraductal papillary mucinous neoplasm of the pancreas.
    J Gastroenterol. 2019 May 20. pii: 10.1007/s00535-019-01592.
    PubMed     Abstract available


    April 2019
  30. MATSUMOTO K, Ohara T, Fujisawa M, Takaki A, et al
    The relationship between the PD-L1 expression of surgically resected and fine-needle aspiration specimens for patients with pancreatic cancer.
    J Gastroenterol. 2019 Apr 29. pii: 10.1007/s00535-019-01586.
    PubMed     Abstract available


    March 2019
  31. LIU B, Kudo A, Kinowaki Y, Ogura T, et al
    A simple and practical index predicting the prognoses of the patients with well-differentiated pancreatic neuroendocrine neoplasms.
    J Gastroenterol. 2019 Mar 12. pii: 10.1007/s00535-019-01570.
    PubMed     Abstract available


    December 2018
  32. ZHU Y, He C, Li X, Cai Y, et al
    Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice.
    J Gastroenterol. 2018 Dec 5. pii: 10.1007/s00535-018-1529.
    PubMed     Abstract available


  33. HASHIMOTO D, Arima K, Nakagawa S, Negoro Y, et al
    Pancreatic cancer arising from the remnant pancreas after pancreatectomy: a multicenter retrospective study by the Kyushu Study Group of Clinical Cancer.
    J Gastroenterol. 2018 Dec 4. pii: 10.1007/s00535-018-01535.
    PubMed     Abstract available


    November 2018
  34. TAKEDA T, Nakai Y, Mizuno S, Suzuki T, et al
    Fluid sequestration is a useful parameter in the early identification of severe disease of acute pancreatitis.
    J Gastroenterol. 2018 Nov 26. pii: 10.1007/s00535-018-1531.
    PubMed     Abstract available


  35. KITANO M, Yoshida T, Itonaga M, Tamura T, et al
    Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer.
    J Gastroenterol. 2018 Nov 7. pii: 10.1007/s00535-018-1519.
    PubMed     Abstract available


    September 2018
  36. MOTOI F, Satoi S, Honda G, Wada K, et al
    A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.
    J Gastroenterol. 2018 Sep 4. pii: 10.1007/s00535-018-1506.
    PubMed     Abstract available


    August 2018
  37. SATO T, Shibata W, Maeda S
    Adhesion molecules and pancreatitis.
    J Gastroenterol. 2018 Aug 23. pii: 10.1007/s00535-018-1500.
    PubMed     Abstract available


    May 2018
  38. YAMAZAKI H, Tauchi S, Kimachi M, Dohke M, et al
    Response to the letter by Dr. Tomoyuki Kawada regarding our manuscript: Independent association between prediabetes and future pancreatic fat accumulation: a 5-year Japanese cohort study.
    J Gastroenterol. 2018 May 12. pii: 10.1007/s00535-018-1475.
    PubMed    


  39. KAWADA T
    Prediabetes and subsequent pancreatic fat accumulation.
    J Gastroenterol. 2018 May 12. pii: 10.1007/s00535-018-1471.
    PubMed    


    April 2018
  40. UCHIDA K, Ynagawa M, Okazaki K
    Response to the Letter by Poddighe et al. regarding our manuscript "Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis".
    J Gastroenterol. 2018 Apr 24. pii: 10.1007/s00535-018-1460.
    PubMed    


  41. OHMOTO A, Morizane C, Kubo E, Takai E, et al
    Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
    J Gastroenterol. 2018 Apr 17. pii: 10.1007/s00535-018-1466.
    PubMed     Abstract available


  42. PODDIGHE D, Brambilla I, Marseglia GL
    Basophils activated via TLR signaling may contribute to pathophysiology of type I autoimmune pancreatitis".
    J Gastroenterol. 2018 Apr 16. pii: 10.1007/s00535-018-1456.
    PubMed    


    March 2018
  43. ENDO A, Shiraishi A, Fushimi K, Murata K, et al
    Impact of continuous regional arterial infusion in the treatment of acute necrotizing pancreatitis: analysis of a national administrative database.
    J Gastroenterol. 2018 Mar 21. pii: 10.1007/s00535-018-1452.
    PubMed     Abstract available


    February 2018
  44. YANAGAWA M, Uchida K, Ando Y, Tomiyama T, et al
    Correction to: Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis.
    J Gastroenterol. 2018 Feb 26. pii: 10.1007/s00535-018-1443.
    PubMed     Abstract available


  45. UCHIDA K, Okazaki K
    Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis.
    J Gastroenterol. 2018 Feb 19. pii: 10.1007/s00535-018-1440.
    PubMed     Abstract available


    January 2018
  46. HAMADA T, Khalaf N, Yuan C, Babic A, et al
    Statin use and pancreatic cancer risk in two prospective cohort studies.
    J Gastroenterol. 2018 Jan 23. pii: 10.1007/s00535-018-1430.
    PubMed     Abstract available


  47. LEE HW, Moon SH, Kim MH, Cho DH, et al
    Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
    J Gastroenterol. 2018 Jan 23. pii: 10.1007/s00535-018-1434.
    PubMed     Abstract available


    December 2017
  48. YAMAZAKI H, Tauchi S, Kimachi M, Dohke M, et al
    Independent association between prediabetes and future pancreatic fat accumulation: a 5-year Japanese cohort study.
    J Gastroenterol. 2017 Dec 13. pii: 10.1007/s00535-017-1422.
    PubMed     Abstract available


    September 2017
  49. YANAGAWA M, Uchida K, Ando Y, Tomiyama T, et al
    Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis.
    J Gastroenterol. 2017 Sep 18. doi: 10.1007/s00535-017-1390.
    PubMed     Abstract available


    August 2017
  50. MASAMUNE A, Kikuta K, Hamada S, Nakano E, et al
    Nationwide survey of hereditary pancreatitis in Japan.
    J Gastroenterol. 2017 Aug 31. doi: 10.1007/s00535-017-1388.
    PubMed     Abstract available


    June 2017
  51. MINE T, Morizane T, Kawaguchi Y, Akashi R, et al
    Clinical practice guideline for post-ERCP pancreatitis.
    J Gastroenterol. 2017 Jun 26. doi: 10.1007/s00535-017-1359.
    PubMed     Abstract available


  52. KAWAKUBO K, Ohnishi S, Kuwatani M, Sakamoto N, et al
    Mesenchymal stem cell therapy for acute and chronic pancreatitis.
    J Gastroenterol. 2017 Jun 23. doi: 10.1007/s00535-017-1363.
    PubMed     Abstract available


    May 2017
  53. OBA A, Kudo A, Akahoshi K, Kishino M, et al
    A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors.
    J Gastroenterol. 2017 May 9. doi: 10.1007/s00535-017-1349.
    PubMed     Abstract available


    April 2017
  54. TSUJI Y, Takahashi N, Isoda H, Koizumi K, et al
    Erratum to: Early diagnosis of pancreatic necrosis based on perfusion CT to predict the severity of acute pancreatitis.
    J Gastroenterol. 2017 Apr 26. doi: 10.1007/s00535-017-1343.
    PubMed    


  55. YOSHIHISA T, Naoki T, Hiroyoshi I, Koji K, et al
    Early diagnosis of pancreatic necrosis based on perfusion CT to predict the severity of acute pancreatitis.
    J Gastroenterol. 2017 Apr 3. doi: 10.1007/s00535-017-1330.
    PubMed     Abstract available


    January 2017
  56. MASAMUNE A, Kikuta K, Nabeshima T, Nakano E, et al
    Nationwide epidemiological survey of early chronic pancreatitis in Japan.
    J Gastroenterol. 2017 Jan 27. doi: 10.1007/s00535-017-1311.
    PubMed     Abstract available


  57. KUBOTA K, Kamisawa T, Okazaki K, Kawa S, et al
    Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients.
    J Gastroenterol. 2017 Jan 6. doi: 10.1007/s00535-016-1302.
    PubMed     Abstract available


    December 2016
  58. HIJIOKA S, Hara K, Mizuno N, Okuno N, et al
    Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms.
    J Gastroenterol. 2016 Dec 24. doi: 10.1007/s00535-016-1297.
    PubMed    


  59. KUWAHARA T, Hirooka Y, Kawashima H, Ohno E, et al
    Quantitative diagnosis of chronic pancreatitis using EUS elastography.
    J Gastroenterol. 2016.
    PubMed     Abstract available


    October 2016
  60. KAMISAWA T, Kuruma S, Chiba K, Tabata T, et al
    Biliary carcinogenesis in pancreaticobiliary maljunction.
    J Gastroenterol. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: